Klow Blend 80mg

Description

Klow Blend 80mg — Advanced Multi-Peptide Research Complex

Klow Blend is a four-peptide research compound combining GHK-Cu (50mg), TB-500 (10mg), BPC-157 (10mg), and KPV (10mg) in a single 80mg lyophilized vial. This advanced formulation builds upon the established Glow Blend by incorporating KPV, a tripeptide fragment of alpha-melanocyte-stimulating hormone (α-MSH) studied for its role in inflammatory signaling pathways.

Composition

• GHK-Cu (50mg): Copper-binding tripeptide studied for its role in extracellular matrix remodeling, collagen synthesis signaling, and metalloproteinase regulation.
• TB-500 (10mg): Thymosin Beta-4 fragment investigated for actin-binding properties and cell migration research in tissue repair models.
• BPC-157 (10mg): Body Protection Compound-15, a pentadecapeptide studied for its interaction with the nitric oxide system, growth factor modulation, and cytoprotective pathways.
• KPV (10mg): A C-terminal tripeptide of α-MSH researched for its interaction with melanocortin receptors and NF-κB inflammatory signaling pathways. Published studies have examined KPV in models of intestinal inflammation and dermal tissue repair.

Research Applications

• Multi-pathway tissue repair and regeneration studies
• Inflammatory signaling modulation research (KPV + BPC-157 synergy)
• Extracellular matrix and collagen pathway investigations
• Comparative studies against individual peptide components and the Glow Blend (3-peptide) formulation

Specifications

• Total Content: 80mg per vial (GHK-Cu 50mg + TB-500 10mg + BPC-157 10mg + KPV 10mg)
• Form: Lyophilized powder
• Purity: ≥98% (HPLC verified, each component)
• Storage: -20°C lyophilized, 2-8°C after reconstitution
• Reconstitution: Bacteriostatic water recommended for multi-use research protocols

How Klow Differs from Glow Blend

Klow Blend contains the same three-peptide base as Glow Blend (GHK-Cu + TB-500 + BPC-157) with the addition of KPV (10mg). The inclusion of KPV provides researchers with a tool to study melanocortin receptor-mediated pathways alongside the tissue remodeling and cytoprotective mechanisms of the base formulation.

References

1. Pickart L, Vasquez-Soltero JM, Margolina A. GHK peptide as a natural modulator of multiple cellular pathways in skin regeneration. BioMed Research International. 2015;2015:648108.
2. Sosne G, Qiu P, Goldstein AL, Wheater M. Biological activities of thymosin β4 defined by active sites in short peptide sequences. FASEB J. 2010;24(7):2144-2151.
3. Sikiric P, et al. Brain-gut axis and pentadecapeptide BPC 157. Current Neuropharmacology. 2016;14(8):857-865.
4. Kannengiesser K, et al. Melanocortin-derived tripeptide KPV has anti-inflammatory potential in murine models of inflammatory bowel disease. Inflammatory Bowel Diseases. 2008;14(3):324-331.

This product is sold strictly for in-vitro research and laboratory use only. Not for human consumption. Researchers are responsible for compliance with all applicable regulations.